NL-OMON26811RecruitingNot Applicable
An open-label, prospective, comparative trial to assess PSA progression on bicalutamide monotherapy versus bicalutamide + dutasteride therapy in patients with advanced and/or metastatic carcinoma of the prostate.
STIWU: Stichting ter bevordering van het Wetenschappelijk Urologisch onderzoek(Foundation for the stimulation of Scientific Urological Research.)0 sites324 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 324
Study Overview
Brief Summary
/A
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Patients aged 18 years and above
- •2. Patients with histologically proven prostate cancer.
Exclusion Criteria
- •1. Patients simultaneously participating in another study.
- •2. Previous or concurrent chemotherapy, 5-alpha reductase inhibitor therapy or hormonal therapy specifically for the treatment of prostate cancer other than temporary neo-adjuvant hormonal therapy administered longer than 1 year prior to study entry.
Investigators
Similar Trials
Completed
Not Applicable
An open, prospective, comparative clinical trial to evaluate the improvement of the colposcopist with the use of DySIS™ compared to conventional colposcopy`.Digital colposcopy (Digitale colposcopie)Human papillomavirus (Humaan papillomavirus)Cervical Intraepithelial Neoplasia (CIN) (Cervicale Intraepitheliale Neoplasie (CIN))NL-OMON28477Forth-Photonics and VU medisch centrum400
Not yet recruiting
Phase 3
A study to compare the effectiveness, benefits and risks of four eye drops prednisolone acetate 1%, dexamethasone 0.1%, loteprednol etabonate 0.5% and difluprednate 0.05% in patients with red, swollen, painful eyes after cataract surgery.CTRI/2020/01/022874Dr DINKAR BERI
Recruiting
Not Applicable
Investigation on the Duration of Extended Adjuvant Letrozole treatment.breast cancer, post-menopausal, aromatase inhibitor, letrozole, extended hormonal therapymamma carcinoom, aromatase remmer, verlengde hormonale therapieNL-OMON23112eiden University Medical Center (LUMC)1,823
Completed
Not Applicable
Tamoxifen and Exemestane Adjuvant Multicenter trial.Breast cancer.NL-OMON22587Erasmus Medical Center - Daniel den Hoed Cancer CenterP.O. Box 52013008 AE ROTTERDAM9,000
Completed
Not Applicable
A randomized, multicentre, open label trial comparing the start of the induction of labor with intravenous oxytocin according to the circadian rhythm with standard care.Induction of labor with intravenous oxytocin.NL-OMON22012AMC:J.J.H. Bakker, Dr.J.A.M. van der Post, Dr.R. de Vos.OLVG: Dr.J.M.M.van LithSLVZ:Drs.A.J.van Veelen400